DOWLING & YAHNKE LLC – Merck & Co., Inc. Transaction History
DOWLING & YAHNKE LLC portfolio value:
$9.10M
portfolio value
DOWLING & YAHNKE LLC quarter portfolio value change:
-5.54%
quarter
Merck & Co., Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +0.09% | 100 shares | -525K | $86.12 | 105.75K |
| Q2 2022 | share | Increase | +0.55% | 581 shares | 1.01M | $91.17 | 105.65K |
| Q1 2022 | share | Increase | +0.69% | 715 shares | 624K | $82.05 | 105.07K |
| Q4 2021 | share | Decrease | -1.68% | -1.77K shares | 26K | $77.14 | 104.36K |
| Q3 2021 | share | Decrease | -0.89% | -951 shares | -356K | $75.11 | 106.14K |
| Q2 2021 | share | Decrease | -2.79% | -3.07K shares | 224K | $77.08 | 107.09K |
| Q1 2021 | share | Decrease | -1.22% | -1.35K shares | -601K | $72.28 | 110.16K |
| Q4 2020 | share | Increase | +5.75% | 6.06K shares | 358K | $76.03 | 111.52K |
| Q3 2020 | share | Increase | +0.26% | 270 shares | 585K | $76.48 | 105.45K |
| Q2 2020 | share | Increase | +0.61% | 642 shares | 87K | $70.79 | 105.18K |
| Q1 2020 | share | Decrease | -2.77% | -2.98K shares | -1.65M | $69.87 | 104.54K |
| Q4 2019 | share | Decrease | -2.46% | -2.71K shares | 477K | $81.94 | 107.52K |
| Q3 2019 | share | Increase | +3.38% | 3.60K shares | 323K | $75.33 | 110.24K |
| Q2 2019 | share | Decrease | -1.51% | -1.63K shares | -61K | $74.54 | 106.63K |
| Q1 2019 | share | Increase | +3.29% | 3.44K shares | 657K | $73.45 | 108.27K |
| Q4 2018 | share | Increase | +2.05% | 2.10K shares | 982K | $67.02 | 104.82K |
| Q3 2018 | share | Decrease | -1.51% | -1.57K shares | 913K | $61.78 | 102.72K |
| Q2 2018 | share | Decrease | -1.29% | -1.36K shares | 549K | $52.5 | 104.29K |
| Q1 2018 | share | Decrease | -1.21% | -1.29K shares | -251K | $46.75 | 105.66K |
| Q4 2017 | share | Increase | 0.00% | 106.95K shares | 5.74M | $47.88 | 106.95K |